Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.

Ito D, Iida M, Iguchi Y, Hashizume A, Yamada S, Kishimoto Y, Komori S, Obara K, Nishisaki S, Yokoi S, Shimamura T, Takemoto Y, Nakatochi M, Akashi T, Hinohara K, Lee-Okada HC, Okada Y, Niwa J, Sobue G, Tanaka S, Takashina K, Yokomizo T, Katsuno M

Open source

DOI: 10.1172/jci.insight.198842
Published: 2026 Aug 10
Container: JCI insight
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci.insight.198842,
  title = {Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.},
  author = {Ito D and Iida M and Iguchi Y and Hashizume A and Yamada S and Kishimoto Y and Komori S and Obara K and Nishisaki S and Yokoi S and Shimamura T and Takemoto Y and Nakatochi M and Akashi T and Hinohara K and Lee-Okada HC and Okada Y and Niwa J and Sobue G and Tanaka S and Takashina K and Yokomizo T and Katsuno M},
  year = {2026},
  journal = {JCI insight},
  doi = {10.1172/jci.insight.198842},
  url = {https://doi.org/10.1172/jci.insight.198842}
}

RIS

TY  - JOUR
TI  - Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.
AU  - Ito D
AU  - Iida M
AU  - Iguchi Y
AU  - Hashizume A
AU  - Yamada S
AU  - Kishimoto Y
AU  - Komori S
AU  - Obara K
AU  - Nishisaki S
AU  - Yokoi S
AU  - Shimamura T
AU  - Takemoto Y
AU  - Nakatochi M
AU  - Akashi T
AU  - Hinohara K
AU  - Lee-Okada HC
AU  - Okada Y
AU  - Niwa J
AU  - Sobue G
AU  - Tanaka S
AU  - Takashina K
AU  - Yokomizo T
AU  - Katsuno M
PY  - 2026
JO  - JCI insight
DO  - 10.1172/jci.insight.198842
UR  - https://doi.org/10.1172/jci.insight.198842
ER  -

APA

D, I., M, I., Y, I., A, H., S, Y., Y, K., S, K., K, O., S, N., S, Y., T, S., Y, T., M, N., T, A., K, H., HC, L., Y, O., J, N., G, S., S, T., K, T., T, Y., & M, K. (2026). Fatty acid amide hydrolase inhibition for treatment of amyotrophic lateral sclerosis.. JCI insight. https://doi.org/10.1172/jci.insight.198842

Source records

pubmed · retrieved 2026-09-26T23:00:57.678Z
europe-pmc · retrieved 2026-09-26T23:00:57.698Z